FGF21 and Hypoglycemia: As previous reported, fasted FGF21−/− mice exhibit impaired activation of the hypothalamic–pituitary–adrenal (HPA) axis and blunted release of corticosterone, which could lead to hypoglycemia and defective hepatic gluconeogenesis [36].